Curated News: NEJM

Filters close
Newswise: Risk of long COVID declined over course of pandemic
15-Jul-2024 2:05 PM EDT
Risk of long COVID declined over course of pandemic
Washington University in St. Louis

The risk of long COVID has declined over the course of the pandemic, although it remains a persistent threat. Researchers from Washington University School of Medicine in St. Louis identified vaccination as a primary factor in reducing the risk of long COVID.

Newswise: George Bakris, internationally recognized hypertension expert, 1952-2024
Released: 11-Jul-2024 5:05 PM EDT
George Bakris, internationally recognized hypertension expert, 1952-2024
University of Chicago Medical Center

Bakris served on the UChicago faculty for 18 years and was director of the Comprehensive Hypertension Center.

Newswise: 1920_ai-chat-image-cedars-sinai.jpg?10000
Released: 11-Jul-2024 11:05 AM EDT
Cedars-Sinai AI Expert Makes Case for Importance of Thoughtful Model Design
Cedars-Sinai

The data fed to artificial intelligence (AI) systems make all the difference on performance, according to David Ouyang, MD, a cardiologist in the Department of Cardiology in the Smidt Heart Institute at Cedars-Sinai.

Newswise: Electroconvulsive therapy or ketamine? Clinical factors affect outcomes
Released: 25-Jun-2024 11:05 AM EDT
Electroconvulsive therapy or ketamine? Clinical factors affect outcomes
UT Southwestern Medical Center

Patients with moderate to severe treatment-resistant depression (TRD) might have better symptom relief from ketamine infusions than from electroconvulsive therapy (ECT), but those with severe TRD could benefit more from ECT early in treatment, an analysis led by a UT Southwestern Medical Center researcher shows. The findings, published in JAMA Network Open, are the first to identify characteristics that distinguish which treatments might benefit TRD patients more.

Newswise: Study Identifies First Drug Therapy for Sleep Apnea
18-Jun-2024 1:05 PM EDT
Study Identifies First Drug Therapy for Sleep Apnea
UC San Diego Health

UC San Diego School of Medicine international study shows new drug improves sleep, health in patients diagnosed with obesity and sleep apnea.

Newswise: Global trial confirms benefit of antacids on bleeding prevention for ventilated patients
12-Jun-2024 12:05 PM EDT
Global trial confirms benefit of antacids on bleeding prevention for ventilated patients
McMaster University

Critically ill patients are at risk of stress-induced upper gastrointestinal bleeding. Now, a global trial led by McMaster University researchers confirms that a widely available drug does prevent upper gastrointestinal bleeding.

10-Jun-2024 4:05 PM EDT
Multicenter Randomized Trial Identifies Method of Preoxygenation That Prevents Hypoxemia and Cardiac Arrest During Emergency Tracheal Intubation
Vanderbilt University Medical Center

Vanderbilt University Medical Center (VUMC) led the Department of the Defense-funded Pragmatic Trial Examining Oxygenation Prior to Intubation PREOXI study comparing the two most commonly used methods used to preoxygenate patients prior to tracheal intubation: preoxygenation with noninvasive ventilation and preoxygenation with an oxygen mask.

7-Jun-2024 10:05 AM EDT
Case study reveals important new details about rare second cancers related to CAR-T therapy
Georgetown University Medical Center

A new detailed analysis of a patient’s second cancer after receiving CAR-T therapy for the initial cancer provides rare but important insights intended to offer helpful guidance for oncologists and pathologists about the clinical presentation and pathologic features involved in a CAR-T related second cancer.

Newswise: Team tests strategies to care for patients with multiple diseases
Released: 11-Jun-2024 10:05 AM EDT
Team tests strategies to care for patients with multiple diseases
UT Southwestern Medical Center

In a large clinical trial, UT Southwestern Medical Center researchers developed a robust model for testing strategies to prevent health problems in patients with multiple chronic conditions.

Newswise: RNA Inhibitor Is Shown Safe and Effective in Reducing a Wide Range of Cholesterol and Triglyceride Levels in the Blood in Mount Sinai-Led Clinical Trial
Released: 29-May-2024 5:30 AM EDT
RNA Inhibitor Is Shown Safe and Effective in Reducing a Wide Range of Cholesterol and Triglyceride Levels in the Blood in Mount Sinai-Led Clinical Trial
Mount Sinai Health System

A small interfering RNA (siRNA) investigational therapy that inhibits a gene involved in lipoprotein metabolism has been shown in a clinical trial led by Mount Sinai researchers to significantly reduce levels of different types of cholesterol and triglycerides in individuals with mixed hyperlipidemia, a condition in which fats build up in the blood.

Released: 24-May-2024 10:05 AM EDT
Raw milk containing H5N1 can infect mice, while lab-based heat treatments greatly reduce the virus
University of Wisconsin–Madison

Consuming raw cow's milk that contains H5N1 avian influenza virus poses an infection risk, but a laboratory process that simulates high-temperature pasteurization reduces the virus in infected milk by more than 99.99%. That's according to a team led by University of Wisconsin–Madison scientists, who reported their findings May 24 in a letter published in the New England Journal of Medicine.

Newswise: Measuring Lung Function More Accurately and More Equitably
16-May-2024 1:30 PM EDT
Measuring Lung Function More Accurately and More Equitably
Harvard Medical School

Race-based assessments of lung function have historically assumed different levels of “normal” for different patient groups. New analysis shows that removing from lung function estimates would increase the number of Black patients diagnosed with serious disease.Greater estimated disease severity would change a patient’s diagnosis, disability compensation, eligibility for certain jobs.

Newswise: Pre- and post-surgical immunotherapy improves outcomes for patients with operable lung cancer
14-May-2024 5:00 PM EDT
Pre- and post-surgical immunotherapy improves outcomes for patients with operable lung cancer
University of Texas MD Anderson Cancer Center

Compared with pre-surgical (neoadjuvant) chemotherapy alone, adding perioperative immunotherapy – given before and after surgery – significantly improved event-free survival (EFS) in patients with resectable early-stage non-small cell lung cancer (NSCLC), according to researchers from The University of Texas MD Anderson Cancer Center.

Released: 13-May-2024 3:05 PM EDT
Texas Tech Researchers Help Confirm First Case of Avian Influenza Transmitted from Cow to Human
Texas Tech University

Researchers from the Biological Threat Response Laboratory played a critical role in testing for the virus.

13-May-2024 9:30 AM EDT
New Treatment in Pipeline for Patients with Hypertrophic Cardiomyopathy
Lahey Hospital & Medical Center

One of the most common genetic heart diseases worldwide, hypertrophic cardiomyopathy (HCM) causes the walls of the left ventricle to become thick and stiff. In about 70 percent of cases, patients with HCM experience obstruction to blood flow, which increases pressures in the heart and can lead to chest pain, shortness of breath and reduced exercise capacity.

Released: 2-May-2024 6:00 AM EDT
Four state-of-the-art, artificial intelligence search engines for histopathology images may not be ready for clinical use
University of California, Los Angeles (UCLA), Health Sciences

Four proposed state-of-the art image search engines for automating search and retrieval of digital histopathology slides were found to be of inadequate performance for routine clinical care. Some had less than 50% accuracy, which is not suitable for clinical practice.

23-Apr-2024 7:05 AM EDT
It’s easier now to treat opioid addiction with medication -- but use has changed little
Michigan Medicine - University of Michigan

In the first year after the sudden removal of a requirement that prescribers get special permission to prescribe medication for opioid addiction, a study finds more prescribers started providing it, but the number of patients receiving it didn't rise very much.

24-Apr-2024 2:05 PM EDT
Researchers Publish Final Results of Key Clinical Trial for Gene Therapy for Sickle Cell Disease
Children's Hospital of Philadelphia

An international consortium published the final results of a key clinical trial of the gene therapy CASGEVY (exagamglogene autotemcel) for the treatment of sickle cell disease in patients 12 years and older with recurrent vaso-occlusive crises (VOCs).

Newswise: UTSW Research: Food allergies, weight-loss surgery, and more
Released: 2-Apr-2024 12:05 PM EDT
UTSW Research: Food allergies, weight-loss surgery, and more
UT Southwestern Medical Center

Roundup of recent research involving UT Southwestern faculty members: Antibody treatment lowers risk for food allergies; Weight-loss surgery support offered for teens; Racial disparities found among pregnant patients with multiple sclerosis; Gestational age increased at start of COVID-19 pandemic



close
1.84842